Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 4 studies | 23% ± 5% | |
| GABAergic neuron | 3 studies | 27% ± 4% | |
| glutamatergic neuron | 3 studies | 32% ± 6% | |
| astrocyte | 3 studies | 28% ± 13% | |
| interneuron | 3 studies | 28% ± 8% | |
| oligodendrocyte | 3 studies | 37% ± 26% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 693.52 | 1445 / 1445 | 99% | 7.44 | 181 / 183 |
| lung | 100% | 658.31 | 576 / 578 | 99% | 6.95 | 1144 / 1155 |
| thymus | 100% | 787.21 | 653 / 653 | 99% | 7.05 | 596 / 605 |
| prostate | 100% | 753.40 | 245 / 245 | 98% | 6.69 | 493 / 502 |
| breast | 100% | 760.24 | 459 / 459 | 98% | 7.43 | 1092 / 1118 |
| ovary | 100% | 618.76 | 180 / 180 | 97% | 5.80 | 418 / 430 |
| stomach | 100% | 679.06 | 359 / 359 | 97% | 6.85 | 277 / 286 |
| pancreas | 100% | 672.57 | 328 / 328 | 97% | 5.35 | 172 / 178 |
| intestine | 100% | 816.24 | 966 / 966 | 96% | 6.63 | 504 / 527 |
| bladder | 100% | 744.29 | 21 / 21 | 95% | 5.33 | 478 / 504 |
| adrenal gland | 100% | 718.67 | 258 / 258 | 95% | 5.64 | 218 / 230 |
| kidney | 100% | 595.39 | 89 / 89 | 94% | 6.64 | 849 / 901 |
| brain | 99% | 453.46 | 2604 / 2642 | 92% | 3.93 | 649 / 705 |
| uterus | 100% | 643.54 | 170 / 170 | 90% | 4.19 | 411 / 459 |
| liver | 100% | 472.53 | 226 / 226 | 87% | 4.02 | 355 / 406 |
| skin | 100% | 749.43 | 1809 / 1809 | 78% | 3.64 | 370 / 472 |
| adipose | 100% | 721.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 753.61 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 666.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 726.55 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 5.25 | 28 / 29 |
| heart | 97% | 480.84 | 831 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 4.86 | 42 / 45 |
| peripheral blood | 79% | 422.94 | 732 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 34% | 1.17 | 27 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0034599 | Biological process | cellular response to oxidative stress |
| GO_0030017 | Cellular component | sarcomere |
| GO_0005634 | Cellular component | nucleus |
| GO_0016491 | Molecular function | oxidoreductase activity |
| GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PYROXD1 |
| Protein name | Pyridine nucleotide-disulphide oxidoreductase domain 1 (cDNA FLJ60446) Pyridine nucleotide-disulphide oxidoreductase domain 1 Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-) |
| Synonyms | |
| Description | FUNCTION: Probable FAD-dependent oxidoreductase; involved in the cellular oxidative stress response . Required for normal sarcomere structure and muscle fiber integrity (By similarity). . |
| Accessions | ENST00000544187.1 ENST00000538582.5 [Q8WU10-2] ENST00000543476.5 ENST00000375266.8 Q8WU10 B4DEW4 ENST00000240651.14 [Q8WU10-1] ENST00000544970.5 B5MDP1 H0YGU0 |
